INVESTIGATIONAL DRUGS FOR
Volunteers & Patients
We empower study participants by educating them about clinical research, enabling them to make informed decisions regarding study participation.
NEW POSSIBILITIES FOR
Investigators
Clinilabs collaborates with investigator sites worldwide to conduct clinical trials that lead to new drug approvals. Become an investigator in our global network!
Experts in CNS Therapeutics
We specialize in a wide range of therapeutic areas with a focus on CNS trials conducted at investigator sites on five continents.
Sleep Disorders
Psychiatric Disorders
Neurological Disorders
New Treatments. New Possibilities.
The mid-sized clinical CRO specializing in first-in-human to Phase 3 trials, with a global core laboratory.
Connect With Us
Connect with us online, or come visit us at
an upcoming industry event!
24th Congress of the European Sleep Research Society
September 25 - September 28 at Congrex SwitzerlandSleep and Circadian Research: New Developments and Regulatory Issues
October 11 - October 12 at Alexandria Mark CenterANESTHESIOLOGY 2018
October 13 - October 17 at Moscone Center
Latest News & Updates
Expansion of Regional Offices
Clinilabs Drug Development Corporation is pleased to announce that it has established two new regional offices in 2017. An office has been established in San Diego, California in order to accommodate the increasing number of [...]
Epilepsy Monitoring Unit
Clinilabs Drug Development Corporation is pleased to announce that it has established a 4-bed epilepsy monitoring unit at its New York City facility. The facility, which boasts a 50-bed inpatient capacity for clinical studies, offers [...]
CNS Sites of the Future
At this year’s CNS Summit, held in Boca Raton, Florida November 1 – 4 2017, attendees participated in a panel discussion that considered the characteristics that investigator sites will have in the future. Many of [...]